NHS antisense RNA 1 (NHS-AS1)

NHS antisense RNA 1 (NHS-AS1) is a long noncoding RNA transcribed from the antisense strand of the NHS gene locus. Like other antisense RNAs, its primary function is to regulate the expression of the corresponding sense gene or nearby genes by binding to sense mRNA or interacting with chromatin and transcriptional machinery. NHS-AS1 belongs to the natural antisense transcript (NAT) family and is classified molecularly as a lncRNA. It modulates gene expression via multiple mechanisms, including transcriptional interference, mRNA stability regulation, and epigenetic modification. Dysregulation of antisense RNAs such as NHS-AS1 can play a role in cancer development by silencing tumor suppressor genes or modulating pathways involved in cell growth and differentiation. NHS-AS1 and similar molecules are being investigated as targets and biomarkers in cancer research and may be manipulated using antisense oligonucleotides or RNA interference approaches, though clinical translation is still in early stages. Safety concerns for targeting such noncoding RNAs include delivery, off-target effects, and unpredictability in complex gene networks[1][3][4][5].

Other names

NHS-AS1NHS antisense RNA 1long non-coding RNA NHS-AS1 (lncRNA NHS-AS1)

ASOs: bind to NHS-AS1 or similar antisense RNA to modulate its function, either by triggering RNase H-mediated RNA degradation, blocking translation, or inducing transcript silencing/decay. RNA interference: experimentally, siRNAs may target antisense RNAs including NHS-AS1 to silence gene expression.